ABBV

AbbVie News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.32 -1.57% 82.60 19:59:05
Close Price Low Price High Price Open Price Previous Close
82.71 82.68 84.26 84.00 83.92
more quote information »

Recent News

Date Time Source Heading
10/27/20209:29IHNWFeaturedIQST - iQSTEL Announces Analyst Report With $0.54 Target PPS
10/20/202008:45NNWBanking on the Next Blockbuster Drug
10/19/202010:53DJNAbbVie Seeks U.S., European OK of Rinvoq in Eczema
10/19/202010:06PRNUSAbbVie Submits Regulatory Applications to FDA and EMA for..
10/19/202009:14EDGARCurrent Report Filing (8-k)
10/19/202008:56PRNUSAbbVie Announces Commencement of Registered Exchange Offers
10/19/202008:01EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/19/202006:04EDGARNotice of Effectiveness (effect)
10/16/202019:34PRNUSVENCLEXTA® (venetoclax) Receives FDA Full Approval for Acute..
10/16/202007:59DJNNIH to Study Three Drugs in Treatment of Covid-19 Patients
10/09/202009:00PRNUSAllergan Aesthetics To Present Data From 4 Abstracts At The..
10/07/202010:33DJNAbbVie's Allergan to Buy Luminera Dermal-Filler Business
10/07/202008:00PRNUSAllergan Aesthetics, an AbbVie Company, Acquires Innovative..
10/06/202008:00PRNUSAbbVie to Host Third-Quarter 2020 Earnings Conference Call
10/02/202016:55EDGARStatement of Changes in Beneficial Ownership (4)
10/02/202016:54EDGARStatement of Changes in Beneficial Ownership (4)
10/02/202016:54EDGARStatement of Changes in Beneficial Ownership (4)
10/02/202016:06EDGARCurrent Report Filing (8-k)
10/02/202008:30PRNUSAbbVie to Present New Data From 15 Abstracts at the 2020..
10/01/202006:01PRNCAPublic coverage of AbbVie's SKYRIZI® for the treatment of..
9/30/202008:45NNWSolving One of the Largest Drivers of Disease: Inflammation
9/28/202009:29DJNAbbVie Gets Orphan Drug Designation for Spinal Cord Injury..
9/28/202008:00PRNUSAbbVie Receives Orphan Drug and Fast Track Designations from..
9/16/202008:00PRNUSMalin Akerman Joins CoolSculpting® and CoolTone™ as U.S...
9/14/202008:00PRNUSAllergan Aesthetics and Skinbetter Science Announce The..
9/11/202011:30PRNUSAbbVie to Present New Data From 18 Abstracts at the..
9/11/202009:39PRNUSAbbVie Declares Quarterly Dividend
9/04/202008:02DJNI-Mab, AbbVie to Collaborate on Cancer Treatment..
9/04/202007:00PRNUSAbbVie and I-Mab Enter Into Global Strategic Partnership for..
9/03/202008:00PRNUSAbbVie to Present at the Morgan Stanley Healthcare..
8/25/202010:24DJNAbbVie Seeks FDA OK for Rinvoq in Adults With Active..
8/25/202008:47DJNAbbVie, Harvard Target Emergent Viral Diseases in $30..
8/25/202008:45PRNUSAbbVie Submits Regulatory Application to FDA for RINVOQ™..
8/25/202008:00PRNUSAbbVie, Harvard University Form Research Alliance to Address..
8/25/202007:29DJNMorphic to Get $20 Million as AbbVie Exercises License..
8/25/202006:30GLOBEMorphic Announces that AbbVie Exercises License Option to..
8/12/202017:45PRNUSNew England Journal of Medicine Publishes Positive Phase 3..
8/04/202013:26DJNVoyager Therapeutics Down 11% on End of AbbVie..
8/04/202009:57EDGARQuarterly Report (10-q)
8/03/202019:21DJNVoyager Therapeutics Down 15% on End of AbbVie..
8/03/202007:30PRNUSMembers Of The COVID R&D Alliance And Quantum Leap..
7/31/202008:43EDGARCurrent Report Filing (8-k)
7/31/202008:32DJNAbbVie Reports 2Q Loss, Allergan-Deal Cost Hurt Bottom Line
7/31/202007:43PRNUSAbbVie Reports Second-Quarter 2020 Financial Results
7/29/202016:58EDGARCurrent Report Filing (8-k)
7/29/202008:45PRNUSAbbVie Announces Positive Phase 3 Data for Atogepant in..
7/28/202018:58DJNCorrection to AbbVie Skin-Treatment Article
7/28/202009:29DJNAbbVie Skin Treatment Successful in Phase 3 Trial
7/28/202008:45PRNUSThird Pivotal Phase 3 Study Shows RINVOQ™ (upadacitinib)..
7/28/202007:00PRNCAWe can eliminate Hepatitis C in Canada by 2030
7/21/202009:50DJNAbbVie Says Rinvoq Meets Endpoints in Second Phase 3 Study..
See more news about this stock »


Your Recent History
NYSE
ABBV
AbbVie
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.